1-1 of 1
E.R. Smith
Close
Sort by
Journal Articles

Phase I Study Demonstrates Activity and Tolerability of Diphtheria Toxin Interleukin-3 Fusion Protein in Patients with AML and MDS.

Arthur E. Frankel, MD, E.R. Smith, T.A. George, J.S. Liu, PhD, J. Lee, S.K. Park, MD, David A. Rizzieri, MD, Donna E. Hogge, MD
Journal: Blood
Blood (2007) 110 (11): 894.
https://doi.org/10.1182/blood.V110.11.894.894
Published: 2007